6.
Springer T
. Complement and the multifaceted functions of VWA and integrin I domains. Structure. 2006; 14(11):1611-6.
PMC: 1712385.
DOI: 10.1016/j.str.2006.10.001.
View
7.
Thanh N, Thuy-Nhien N, Tuyen N, Tong N, Nha-Ca N, Dong L
. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam. Malar J. 2017; 16(1):27.
PMC: 5237149.
DOI: 10.1186/s12936-017-1680-8.
View
8.
Lin L, Huang H, Liang X, Xie D, Chen J, Wei H
. Genetic diversity and natural selection on the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium falciparum on Bioko Island, Equatorial Guinea and global comparative analysis. Malar J. 2021; 20(1):124.
PMC: 7922716.
DOI: 10.1186/s12936-021-03664-8.
View
9.
Moorthy V, Imoukhuede E, Milligan P, Bojang K, Keating S, Kaye P
. A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults. PLoS Med. 2004; 1(2):e33.
PMC: 524376.
DOI: 10.1371/journal.pmed.0010033.
View
10.
Muller H, Scarselli E, Crisanti A
. Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum in parasite-host cell interactions. Parassitologia. 1993; 35 Suppl:69-72.
View
11.
Ahmed M, Lau Y, Quan F
. Diversity and natural selection on the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium knowlesi in Malaysia. Malar J. 2018; 17(1):274.
PMC: 6062916.
DOI: 10.1186/s12936-018-2423-1.
View
12.
Mehrizi A, Jafari Zadeh A, Zakeri S, Djadid N
. Population genetic structure analysis of thrombospondin-related adhesive protein (TRAP) as a vaccine candidate antigen in worldwide Plasmodium falciparum isolates. Infect Genet Evol. 2020; 80:104197.
DOI: 10.1016/j.meegid.2020.104197.
View
13.
Tonkin M, Grujic O, Pearce M, Crawford J, Boulanger M
. Structure of the micronemal protein 2 A/I domain from Toxoplasma gondii. Protein Sci. 2010; 19(10):1985-90.
PMC: 2998732.
DOI: 10.1002/pro.477.
View
14.
Atta H, Zamani G
. The progress of Roll Back Malaria in the Eastern Mediterranean Region over the past decade. East Mediterr Health J. 2009; 14 Suppl:S82-9.
View
15.
Mensah V, Gueye A, Ndiaye M, Edwards N, Wright D, Anagnostou N
. Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal. PLoS One. 2016; 11(12):e0167951.
PMC: 5158312.
DOI: 10.1371/journal.pone.0167951.
View
16.
Battle K, Lucas T, Nguyen M, Howes R, Nandi A, Twohig K
. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study. Lancet. 2019; 394(10195):332-343.
PMC: 6675736.
DOI: 10.1016/S0140-6736(19)31096-7.
View
17.
Neafsey D, Juraska M, Bedford T, Benkeser D, Valim C, Griggs A
. Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med. 2015; 373(21):2025-2037.
PMC: 4762279.
DOI: 10.1056/NEJMoa1505819.
View
18.
Heide J, Vaughan K, Sette A, Jacobs T, Schulze Zur Wiesch J
. Comprehensive Review of Human -Specific CD8+ T Cell Epitopes. Front Immunol. 2019; 10:397.
PMC: 6438266.
DOI: 10.3389/fimmu.2019.00397.
View
19.
Barry A, Arnott A
. Strategies for designing and monitoring malaria vaccines targeting diverse antigens. Front Immunol. 2014; 5:359.
PMC: 4112938.
DOI: 10.3389/fimmu.2014.00359.
View
20.
Librado P, Rozas J
. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009; 25(11):1451-2.
DOI: 10.1093/bioinformatics/btp187.
View